Cerus (CERS) Shares Outstanding (Diluted) (2010 - 2026)
Cerus (CERS) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 580.70 Mn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 457.00 Mn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 393.60 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 873.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 968.53 Mn |
| 10 | Cerus | 598.93 Mn | 518.50 Mn | 27.89 Mn | 194.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.14 Mn |
| Dec 31, 2025 | 190.59 Mn |
| Sep 30, 2025 | 191.83 Mn |
| Jun 30, 2025 | 191.30 Mn |
| Mar 31, 2025 | 187.07 Mn |
| Dec 31, 2024 | 184.56 Mn |
| Sep 30, 2024 | 185.42 Mn |
| Jun 30, 2024 | 184.98 Mn |
| Mar 31, 2024 | 182.09 Mn |
| Dec 31, 2023 | 180.27 Mn |
| Sep 30, 2023 | 180.94 Mn |
| Jun 30, 2023 | 180.61 Mn |
| Mar 31, 2023 | 178.27 Mn |
| Dec 31, 2022 | 176.55 Mn |
| Sep 30, 2022 | 177.24 Mn |
| Jun 30, 2022 | 176.94 Mn |
| Mar 31, 2022 | 174.48 Mn |
| Dec 31, 2021 | 171.28 Mn |
| Sep 30, 2021 | 171.90 Mn |
| Jun 30, 2021 | 163.95 Mn |